HERON THERAPEUTICS INC (HRTX)
US4277461020 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to HRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.12. This target is 461.42% above the current price.
HRTX was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about HRTX.
In the previous month the buy percentage consensus was at a similar level.
HRTX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-13 | Needham | Maintains | Buy -> Buy |
| 2024-09-25 | Needham | Reiterate | Buy -> Buy |
| 2024-08-07 | Needham | Reiterate | Buy -> Buy |
| 2024-06-13 | Rodman & Renshaw | Initiate | Buy |
| 2024-05-16 | Needham | Reiterate | Buy -> Buy |
| 2024-05-08 | Needham | Reiterate | Buy -> Buy |
| 2024-04-23 | Capital One | Initiate | Overweight |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-03-13 | Needham | Maintains | Buy -> Buy |
| 2023-11-15 | Needham | Maintains | Buy -> Buy |
| 2023-08-15 | Needham | Reiterate | Buy -> Buy |
| 2023-07-25 | Needham | Maintains | Buy -> Buy |
| 2023-05-12 | Needham | Maintains | Buy -> Buy |
| 2023-04-21 | Needham | Reiterate | Buy |
| 2023-03-24 | Needham | Maintains | Buy |
| 2023-03-24 | Evercore ISI Group | Maintains | Outperform |
| 2022-11-09 | Needham | Maintains | Buy |
| 2022-06-30 | Needham | Maintains | Buy |
| 2022-05-10 | Needham | Maintains | Buy |